Level up your trading with our powerful tools and real-time insights all in one place.
The current CDNA market cap is 1.32B. The company's latest EPS is USD -3.5478 and P/E is -6.92.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 67.19M | 65.57M | 72.05M | 92.27M | 82.88M |
| Operating Income | -28.78M | -122.63M | -19.34M | -4.1M | -10.49M |
| Net Income | -23.49M | -118.1M | -16.66M | -1.39M | -7.41M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 127.07M | 192.19M | 296.4M | 321.79M | 280.32M |
| Operating Income | -24.53M | -22.53M | -29.73M | -77.23M | -203.36M |
| Net Income | -21.97M | -18.71M | -30.66M | -76.61M | -190.28M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 501.18M | 466.83M | 452.41M | 466.78M | 476.99M |
| Total Liabilities | 107.05M | 205.5M | 196.18M | 202.11M | 203.74M |
| Total Equity | 394.13M | 261.33M | 256.23M | 264.67M | 273.25M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 151.74M | 368.51M | 566.62M | 542.99M | 466.83M |
| Total Liabilities | 52.74M | 90.83M | 100.75M | 112.08M | 205.5M |
| Total Equity | 99M | 277.68M | 465.88M | 430.91M | 261.33M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.01M | -18.39M | -15.31M | 3.64M | 16.16M |
| Investing | -921k | 40.45M | 27.66M | 16.03M | 1.63M |
| Financing | -2.73M | -29.61M | -1.28M | -6.13M | -4.7M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.77M | 33.43M | -19.29M | -25.24M | -18.39M |
| Investing | -22.58M | -100.39M | 47.71M | -228.5M | 40.45M |
| Financing | -132k | 163.15M | 185.64M | -4.54M | -29.61M |
| Market Cap | 1.32B |
| Price to Earnings Ratio | -6.92 |
| Price to Sales Ratio | 4.7 |
| Price to Cash Ratio | 16.01 |
| Price to Book Ratio | 5.04 |
| Dividend Yield | - |
| Shares Outstanding | 53.63M |
| Average Volume (1 week) | 867.8k |
| Average Volume (1 Month) | 872.38k |
| 52 Week Change | 151.69% |
| 52 Week High | 34.84 |
| 52 Week Low | 7.42 |
| Spread (Intraday) | 1.2 (4.72%) |
| Company Name | CareDx Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.caredx.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
